YOLONO owner Contact Information online
from Endo Pharmaceuticals Inc.
YOLONO
US serial number:85183547
Application filling date:Nov. 23, 2010
Register:Principal
Mark type:Trademark, Service Mark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Dec. 03, 2012
Publication date:Sep. 06, 2011
Abandoned date:Dec. 03, 2012
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations, namely, anti-psychotics, anti-cancer preparations, anticholinergics, hormone suppressants and 5-alpha reductase inhibitors
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: A
Services:Pharmaceutical preparations
namely
anti-psychotics
anti-cancer preparations
anticholinergics
hormone suppressants and 5-alpha reductase inhibitors
Current owner owner name:Endo Pharmaceuticals Inc.
Current owner owner address:100 Endo Boulevard
Chadds Ford,
PENNSYLVANIA
UNITED STATES
19317
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:James R. Meyer
Attorney email:jmeyer@schnader.com
Attorney docket number:0222552-0709
Attorney email authorized:Yes
Correspondent name address:James R. Meyer
SCHNADER HARRISON SEGAL & LEWIS LLP
1600 MARKET STREET, STE 3600
PHILADELPHIA,
PENNSYLVANIA
UNITED STATES
19103
Correspondent email:trademarks@schnader.com
Correspondent email authorized:Yes
Trademark staff tm attorney:MICHOS, JOHN E
Trademark staff law office assigned YOLONO:LAW OFFICE 105
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (21) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Sep. 06, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
